Uncovers New Explanation for the Spread of Key Protein Within the Brain
LOWELL, Mass. - A team of researchers at UMass Lowell has found a new mechanism by which a key protein associated with Alzheimer’s disease can spread within the human brain.
The research, led by UMass Lowell biological sciences professor Garth Hall, gives new hope that the disease may someday be cured. It provides a new explanation of how the protein tau, a normal human protein that becomes toxic in Alzheimer’s patients, can appear in their cerebrospinal fluid (CSF). The findings of the team from the UMass Lowell Center for Cellular Neuroscience and Neurodegeneration Research appear in the February issue of the Journal of Alzheimer’s Disease.
“My team has discovered two different ways in which tau is secreted by neurons, or brain cells,” said Hall, who has spent more than 20 years studying Alzheimer’s on the cellular level using larval sea lampreys as a model system. “This might explain how tau-containing lesions seem to propagate between adjacent, interconnected parts of the brain during the development of the disease.”
Until very recently, it was universally assumed by scientists that tau is never secreted from or transferred between neurons, and that CSF-tau only appears after many neurons have died and irreversible harm has been done to the brain.
“That tau secretion can occur via two distinct mechanisms strongly indicates that it is biologically ‘real’ and is not just tau protein leaking out of dead neurons,” said Hall. “The fact that it occurs in a pattern that reproduces what is seen in the CSF of Alzheimer’s patients holds out hope that patients in early stages of the disease might someday be cured. If we can distinguish secreted tau from tau that is released from dying neurons in CSF samples, then maybe we can diagnose Alzheimer’s in time to stop the disease before the neurons die.”
Hall, together with graduate student WonHee Kim and UMass Lowell, has filed a provisional patent application in connection with a novel approach to the early diagnosis of Alzheimer’s that is based on their studies of tau secretion.
As many as 5.3 million people in the United States are living with the disease, according to the Alzheimer’s Association. The seventh-leading cause of death among senior citizens, Alzheimer’s is the most common form of dementia and will soon become America’s most expensive health care burden.
UMass Lowell, with a national reputation in science, engineering and technology, is committed to educating students for lifelong success in a diverse world and conducting research and outreach activities that sustain the economic, environmental and social health of the region. UML offers its 13,000 students more than 120 degree choices, internships, five-year combined bachelor’s to master’s programs and doctoral studies in the colleges of Arts and Sciences, Engineering and Management, the School of Health and Environment, and the Graduate School of Education. www.uml.edu.
For more information, contact firstname.lastname@example.org or 978-934-3224